Shandong Weigao Group Medical Polymer Company Limited
SHWGF
$0.7477
$0.101615.73%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.82B | 1.81B | 1.80B | 1.83B | 1.87B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.82B | 1.81B | 1.80B | 1.83B | 1.87B |
| Cost of Revenue | 910.81M | 908.03M | 903.45M | 917.75M | 935.88M |
| Gross Profit | 908.51M | 901.33M | 892.43M | 912.15M | 935.95M |
| SG&A Expenses | 505.56M | 514.88M | 523.15M | 531.54M | 542.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.50B | 1.51B | 1.51B | 1.53B | 1.56B |
| Operating Income | 316.02M | 301.37M | 286.21M | 297.34M | 310.09M |
| Income Before Tax | 354.97M | 334.82M | 314.08M | 324.51M | 336.65M |
| Income Tax Expenses | 54.35M | 47.66M | 40.90M | 42.28M | 43.92M |
| Earnings from Continuing Operations | 300.62 | 287.15 | 273.18 | 282.23 | 292.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.35M | -10.87M | -8.37M | -8.43M | -8.53M |
| Net Income | 287.26M | 276.28M | 264.81M | 273.80M | 284.20M |
| EBIT | 316.02M | 301.37M | 286.21M | 297.34M | 310.09M |
| EBITDA | 444.17M | 427.11M | 409.28M | 420.04M | 432.87M |
| EPS Basic | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Normalized Basic EPS | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 |
| EPS Diluted | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Normalized Diluted EPS | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 |
| Average Basic Shares Outstanding | 18.15B | 18.14B | 18.12B | 18.12B | 18.12B |
| Average Diluted Shares Outstanding | 18.37B | 18.35B | 18.33B | 18.22B | 18.22B |
| Dividend Per Share | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
| Payout Ratio | 42.23% | 40.37% | 38.26% | 37.00% | 35.65% |